| | T. Rowe Price Capital Appreciation | PRWCX | 35.57 | +0.76% | 33.08B | 31/05 | |
| | T. Rowe Price Blue Chip Growth | TRBCX | 174.76 | +0.07% | 30.79B | 31/05 | |
| | T. Rowe Price Capital Appreciation I | TRAIX | 35.58 | +0.76% | 26.59B | 31/05 | |
| | T. Rowe Price Blue Chip Growth I | TBCIX | 175.79 | +0.07% | 27.23B | 31/05 | |
| | T. Rowe Price Instl Large Cap Growth | TRLGX | 75.10 | +0.27% | 21.04B | 31/05 | |
| | T. Rowe Price Growth Stock I | PRUFX | 98.25 | +0.20% | 14.43B | 31/05 | |
| | T. Rowe Price Dividend Growth | PRDGX | 76.73 | +1.25% | 12.69B | 31/05 | |
| | T. Rowe Price Mid-Cap Growth I | RPTIX | 103.88 | +0.32% | 12.43B | 31/05 | |
| | T. Rowe Price Mid-Cap Growth | RPMGX | 103.61 | +0.31% | 12.22B | 31/05 | |
| | T. Rowe Price Growth Stock | PRGFX | 97.90 | +0.20% | 12.47B | 31/05 | |
| | T. Rowe Price New Horizons I | PRJIX | 54.62 | -0.04% | 10.77B | 31/05 | |
| | T. Rowe Price Dividend Growth I | PDGIX | 76.71 | +1.27% | 11.1B | 31/05 | |
| | T. Rowe Price New Horizons | PRNHX | 54.28 | -0.04% | 9.14B | 31/05 | |
| | T. Rowe Price Health Sciences | PRHSX | 92.25 | +1.00% | 8.87B | 31/05 | |
| | T. Rowe Price Equity Index 500 I | PRUIX | 139.09 | +0.81% | 9.32B | 31/05 | |
| | T. Rowe Price Equity Income | PRFDX | 36.67 | +1.80% | 8.51B | 31/05 | |
| | T. Rowe Price Equity Income I | REIPX | 36.64 | +1.81% | 8.23B | 31/05 | |
| | T. Rowe Price Equity Index 500 | PREIX | 139.06 | +0.81% | 7.7B | 31/05 | |
| | T. Rowe Price New America Growth | PRWAX | 72.78 | +0.50% | 7.47B | 31/05 | |
| | T. Rowe Price Overseas Stock I | TROIX | 13.25 | +0.99% | 6.45B | 31/05 | |
![[주간IPO] '공모규모 4000억원 안팎' 게임 대어 시프트업, 수요예측 출격 등](https://i-invdn-com.investing.com/news/external-images-thumbnails/pic427f795c6ba0060e5c226e5486c5abe3.jpg)
